Cardiac sarcoidosis (CS) results from epithelioid cell granulomas infiltrating the myocardium
and predisposing to conduction disturbances, ventricular tachyarrhythmias, and heart …

Cardiac sarcoidosis (CS) is a form of inflammatory cardiomyopathy associated with
significant clinical complications such as high-degree atrioventricular block, ventricular …

Cardiac sarcoidosis is an infiltrative cardiomyopathy that results from granulomatous
inflammation of the myocardium and may present with high-grade conduction disease …

Cardiac sarcoidosis (CS) is a potentially serious form of infiltrative cardiomyopathy. Despite
scarce evidence, immunosuppressive treatment is generally recommended, but local …

Sarcoidosis is a systemic disease with unclear etiology characterized by the accumulation of
noncaseating, immune granulomas in affected tissues. In cardiac sarcoidosis (CS), white …

Sarcoidosis is a systemic disorder characterized by non-necrotizing granulomatous
inflammation and fibrosis affecting multiple organs, notably the lungs and lymph nodes …

Sarcoidosis is an inflammatory multisystemic disease of unknown etiology characterized by
the formation of non-caseating granulomas. Sarcoidosis can affect any organ, predominantly …

Abstract Background 18 F-Fluorodeoxyglucose (18 F-FDG) positron emission tomography
(PET)/magnetic resonance (MR) can identify inflammation and fibrosis, which are high-risk …

Cardiac sarcoidosis is a rare but potentially life-threatening condition characterized by the
formation of noncaseating granulomas in the myocardium. The diagnosis of cardiac …

Background Serial positron emission tomography (PET) imaging is routinely used to monitor
treatment response in patients with suspected cardiac sarcoidosis (CS). Corticosteroids …